Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery
Citations Over TimeTop 10% of 2017 papers
Abstract
Development of high-fidelity three-dimensional (3D) models to recapitulate the tumor microenvironment is essential for studying tumor biology and discovering anticancer drugs. Here we report a method to engineer the 3D microenvironment of human tumors, by encapsulating cancer cells in the core of microcapsules with a hydrogel shell for miniaturized 3D culture to obtain avascular microtumors first. The microtumors are then used as the building blocks for assembling with endothelial cells and other stromal cells to create macroscale 3D vascularized tumor. Cells in the engineered 3D microenvironment can yield significantly larger tumors in vivo than 2D-cultured cancer cells. Furthermore, the 3D vascularized tumors are 4.7 and 139.5 times more resistant to doxorubicin hydrochloride (a commonly used chemotherapy drug) than avascular microtumors and 2D-cultured cancer cells, respectively. Moreover, this high drug resistance of the 3D vascularized tumors can be overcome by using nanoparticle-mediated drug delivery. The high-fidelity 3D tumor model may be valuable for studying the effect of microenvironment on tumor progression, invasion, and metastasis and for developing effective therapeutic strategy to fight against cancer.
Related Papers
- → Functional characterization of two stromal cell lines that support B lymphopoiesis.(1990)51 cited
- → STUDIES ON THE MECHANISMS FOR ACTION OF FIBROBLAST GROWTH FACTORS IN STROMAL CELLS OF HYPERPLASTIC HUMAN PROSTATE(1995)1 cited
- → [Effect of prostate peripheral zones stromal cells on the proliferation of prostate cells by overexpression of LMO2 gene].(2016)
- → Targeting stromal-derived Gremlin1 to control Multiple Myeloma disease development(2019)
- → Classification of muscle-invasive bladder cancer based on tumor stromal compartment(2020)